Activation of genes for growth factor and cytokine pathways late in chondrogenic differentiation of ATDC5 cells

Genomics

Volumn 88, Issue 1, 2006, Pages 52-64

  Osawa, Aki ^a,b   Kato, Masaki ^a   Matsumoto, Eriko ^a   Iwase, Katsuro ^a   Sugimoto, Takashi ^c   Matsui, Tsutomu ^a   Ishikura, Hiroshi ^a   Sugano, Sumio ^d   Kurosawa, Hisashi ^b   Takiguchi, Masaki ^a   Seki, Naohiko ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HITACHI LTD   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chemokine; Chondrocyte; Endochondral ossification; Hematopoietic cell; In situ hybridization; Oligo capping; Osteoprogenitor cell

Indexed keywords

BONE MORPHOGENETIC PROTEIN; COMPLEMENTARY DNA; CYTOKINE; DECORIN; GROWTH FACTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL STIMULATION; CHONDROGENESIS; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; FETUS; GENE ACTIVATION; GENE CLUSTER; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; HYPERTROPHY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHONDROCYTES; CHONDROGENESIS; CYTOKINES; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE LIBRARY; GLYCOPROTEINS; GROWTH SUBSTANCES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOGLYCANS; UP-REGULATION;

EID: 33744908577     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2006.02.013     Document Type: Article

References (71)

1. Kronenberg H.M. Developmental regulation of the growth plate. Nature 423 (2003) 332-336
2. Dailey L., Laplantine E., Priore R., and Basilico C. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J. Cell Biol. 161 (2003) 1053-1066
3. Wahl M., et al. Transcriptome analysis of early chondrogenesis in ATDC5 cells induced by bone morphogenetic protein 4. Genomics 83 (2004) 45-58
4. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., and de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16 (2002) 2813-2828
5. Lefebvre V., Li P., and de Crombrugghe B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 17 (1998) 5718-5733
6. Komori T., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
7. Otto F., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 (1997) 765-771
8. Yoshida C.A., et al. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev. 18 (2004) 952-963
9. Shukunami C., et al. Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor. J. Cell Biol. 133 (1996) 457-468
10. Shukunami C., et al. Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J. Bone Miner. Res. 12 (1997) 1174-1188
11. Suzuki Y., and Sugano S. Construction of a full-length enriched and a 5′-end enriched cDNA library using the oligo-capping method. Methods Mol. Biol. 221 (2003) 73-91
12. Iozzo R.V. The biology of the small leucine-rich proteoglycans: functional network of interactive proteins. J. Biol. Chem. 274 (1999) 18843-18846
13. Ameye L., and Young M.F. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12 (2002) 107R-116R
14. Kato M., et al. Identification of sonic hedgehog-responsive genes using cDNA microarray. Biochem. Biophys. Res. Commun. 289 (2001) 472-478
15. Castagnola P., Dozin B., Moro G., and Cancedda R. Changes in the expression of collagen genes show two stages in chondrocyte differentiation in vitro. J. Cell Biol. 106 (1988) 461-467
16. Schmid T.M., and Linsenmayer T.F. Immunohistochemical localization of short chain cartilage collagen (type X) in avian tissues. J. Cell Biol. 100 (1985) 598-605
17. Cornish J., Naot D., and Reid I.R. Adrenomedullin: a regulator of bone formation. Regul. Pept. 112 (2003) 79-86
18. Chosa E., et al. Expression of adrenomedullin and its receptor by chondrocyte phenotype cells. Biochem. Biophys. Res. Commun. 303 (2003) 379-386
19. Kawasaki K., Suzuki T., and Weiss K.M. Genetic basis for the evolution of vertebrate mineralized tissue. Proc. Natl. Acad. Sci. USA 101 (2004) 11356-11361
20. Molteni A., Modrowski D., Hott M., and Marie P.J. Differential expression of fibroblast growth factor receptor -1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro. Bone 24 (1999) 337-347
21. Yamaguchi Y., Mann D.M., and Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346 (1990) 281-284
22. Hildebrand A., et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J. 302 Pt. 2 (1994) 527-534
23. Kizawa H., et al. An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat. Genet. 37 (2005) 138-144
24. Bentz H., et al. Transforming growth factor-beta 2 enhances the osteoinductive activity of a bovine bone-derived fraction containing bone morphogenetic protein-2 and 3. Matrix 11 (1991) 269-275
25. Wan M., and Cao X. BMP signaling in skeletal development. Biochem. Biophys. Res. Commun. 328 (2005) 651-657
26. Scholzen T., et al. The murine decorin: complete cDNA cloning, genomic organization, chromosomal assignment, and expression during organogenesis and tissue differentiation. J. Biol. Chem. 269 (1994) 28270-28281
27. Wilda M., et al. A comparison of the expression pattern of five genes of the family of small leucine-rich proteoglycans during mouse development. J. Bone Miner. Res. 15 (2000) 2187-2196
28. Takeuchi Y., Kodama Y., and Matsumoto T. Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. J. Biol. Chem. 269 (1994) 32634-32638
29. Funderburgh J.L., et al. Mimecan, the 25-kDa corneal keratan sulfate proteoglycan, is a product of the gene producing osteoglycin. J. Biol. Chem. 272 (1997) 28089-28095
30. Bentz H., et al. Purification and characterization of a unique osteoinductive factor from bovine bone. J. Biol. Chem. 264 (1989) 20805-20810
31. Serra R., and Chang C. TGF-beta signaling in human skeletal and patterning disorders. Birth Defects Res. C Embryo Today 69 (2003) 333-351
32. Zhang X., et al. Primary murine limb bud mesenchymal cells in long-term culture complete chondrocyte differentiation: TGF-beta delays hypertrophy and PGE2 inhibits terminal differentiation. Bone. 34 (2004) 809-817
33. Iozzo R.V., Moscatello D.K., McQuillan D.J., and Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem. 274 (1999) 4489-4492
34. Hedbom E., and Heinegard D. Interaction of a 59-kDa connective tissue matrix protein with collagen I and collagen II. J. Biol. Chem. 264 (1989) 6898-6905
35. Weber I.T., Harrison R.W., and Iozzo R.V. Model structure of decorin and implications for collagen fibrillogenesis. J. Biol. Chem. 271 (1996) 31767-31770
36. Bhide V.M., et al. Collagen phagocytosis by fibroblasts is regulated by decorin. J. Biol. Chem. 280 (2005) 23103-23113
37. Hoshi K., Kemmotsu S., Takeuchi Y., Amizuka N., and Ozawa H. The primary calcification in bones follows removal of decorin and fusion of collagen fibrils. J. Bone Miner. Res. 14 (1999) 273-280
38. Chen L., Fink T., Zhang X.Y., Ebbesen P., and Zachar V. Quantitative transcriptional profiling of ATDC5 mouse progenitor cells during chondrogenesis. Differentiation 73 (2005) 350-363
39. James C.G., Appleton C.T., Ulici V., Underhill T.M., and Beier F. Microarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy. Mol. Biol. Cell. 16 (2005) 5316-5333
40. Nam J.O., et al. Identification of the alphavbeta3 integrin-interacting motif of (ig-h3 and its anti-angiogenic effect. J. Biol. Chem. 278 (2003) 25902-25909
41. Thapa N., Kang K.B., and Kim I.S. Beta ig-h3 mediates osteoblast adhesion and inhibits differentiation. Bone 36 (2005) 232-242
42. Ara T., et al. Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny. Immunity 19 (2003) 257-267
43. Wright L.M., et al. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Bone 36 (2005) 840-853
44. Grassi F., et al. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J. Cell. Physiol. 199 (2004) 244-251
45. Kim H., Li Q., Hempstead B.L., and Madri J.A. Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. J. Biol. Chem. 279 (2004) 33538-33546
46. Lean J.M., Murphy C., Fuller K., and Chambers T.J. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J. Cell. Biochem. 87 (2002) 386-393
47. Lisignoli G., et al. Human osteoblasts express functional CXC chemokine receptors 3 and 5: activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and beta-N-acetylhexosaminidase release. J. Cell. Physiol. 194 (2003) 71-79
48. Samal B., et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol. Cell. Biol. 14 (1994) 1431-1437
49. Jia S.H., et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J. Clin. Invest. 113 (2004) 1318-1327
50. Kieswetter K., Schwartz Z., Alderete M., Dean D.D., and Boyan B.D. Platelet derived growth factor stimulates chondrocyte proliferation but prevents endochondral maturation. Endocrine 6 (1997) 257-264
51. Zhou F.H., Foster B.K., Sander G., and Xian C.J. Expression of proinflammatory cytokines and growth factors at the injured growth plate cartilage in young rats. Bone 35 (2004) 1307-1315
52. Tapp H., Hernandez D.J., Neame P.J., and Koob T.J. Pleiotrophin inhibits chondrocyte proliferation and stimulates proteoglycan synthesis in mature bovine cartilage. Matrix Biol. 18 (1999) 543-556
53. Tare R.S., Oreffo R.O., Clarke N.M., and Roach H.I. Pleiotrophin/osteoblast-stimulating factor 1: dissecting its diverse functions in bone formation. J. Bone Miner. Res. 17 (2002) 2009-2020
54. Meighan-Mantha R.L., et al. The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J. Biol. Chem. 274 (1999) 33166-33176
55. Wiley S.R., et al. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15 (2001) 837-846
56. Chicheportiche Y., et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272 (1997) 32401-32410
57. Okazaki N., et al. Novel factor highly conserved among eukaryotes controls sexual development in fission yeast. Mol. Cell. Biol. 18 (1998) 887-895
58. Hiroi N., et al. Mammalian Rcd1 is a novel transcriptional cofactor that mediates retinoic acid-induced cell differentiation. EMBO J. 21 (2002) 5235-5244
59. Gregory R.C., et al. Subtraction cloning and initial characterization of novel epo-immediate response genes. Cytokine 12 (2000) 845-857
60. Hiraoka A., et al. Cloning, expression, and characterization of a cDNA encoding a novel human growth factor for primitive hematopoietic progenitor cells. Proc. Natl. Acad. Sci. USA 94 (1997) 7577-7582
61. van Bezooijen R.L., Farih-Sips H.C., Papapoulos S.E., and Lowik C.W. Interleukin-17: a new bone acting cytokine in vitro. J. Bone Miner. Res. 14 (1999) 1513-1521
62. Miyakoshi N., et al. Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism. Endocrinology 142 (2001) 2641-2648
63. Fernandez-Tornero C., et al. Synthesis of the blood circulating C-terminal fragment of insulin-like growth factor (IGF)-binding protein-4 in its native conformation: crystallization, heparin and IGF binding, and osteogenic activity. J. Biol. Chem. 280 (2005) 18899-18907
64. Suda T., Nakamura I., Jimi E., and Takahashi N. Regulation of osteoclast function. J. Bone Miner. Res. 12 (1997) 869-879
65. van Wesenbeeck L., et al. The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification. Proc. Natl. Acad. Sci. USA 99 (2002) 14303-14308
66. Lorenzo P., et al. Identification and characterization of asporin: a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. J. Biol. Chem. 276 (2001) 12201-12211
67. Henry S.P., et al. Expression pattern and gene characterization of asporin: a newly discovered member of the leucine-rich repeat protein family. J. Biol. Chem. 276 (2001) 12212-12221
68. Yoshikawa T., et al. Isolation of novel mouse genes differentially expressed in brain using cDNA microarray. Biochem. Biophys. Res. Commun. 275 (2000) 532-537
69. Morse M. Formic acid-sodium citrate decalcification and butyl alcohol dehydration of teeth and bones for sectioning in paraffin. J. Dent. Res. 24 (1945) 143-153
70. Shibata Y., Fujita S., Takahashi H., Yamaguchi A., and Koji T. Assessment of decalcifying protocols for detection of specific RNA by non-radioactive in situ hybridization in calcified tissues. Histochem. Cell Biol. 113 (2000) 153-159
71. Iwase K., et al. Precise distribution of neuronal nitric oxide synthase mRNA in the rat brain revealed by non-radioisotopic in situ hybridization. Mol. Brain Res. 53 (1998) 1-12